Osaic Holdings’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.4K Sell
16,471
-2,939
-15% -$14.9K ﹤0.01% 4866
2025
Q4
$82.7K Buy
19,410
+2,700
+16% +$10.3K ﹤0.01% 4863
2025
Q3
$52.8K Buy
16,710
+500
+3% +$1.13K ﹤0.01% 5277
2025
Q2
$36.8K Buy
16,210
+860
+6% +$1.39K ﹤0.01% 5261
2025
Q1
$9.76K Buy
15,350
+14,480
+1,664% +$11.2K ﹤0.01% 5799
2024
Q4
$896 Sell
870
-30
-3% -$32 ﹤0.01% 6875
2024
Q3
$1.06K Hold
900
﹤0.01% 6826
2024
Q2
$1.1K Buy
+900
New +$1.79K ﹤0.01% 6792
2023
Q3
Sell
-15,350
Closed -$28.6K 7420
2023
Q2
$28.6K Hold
15,350
﹤0.01% 5323
2023
Q1
$24.6K Sell
15,350
-14
-0.1% -$32 ﹤0.01% 5449
2022
Q4
$25K Hold
15,364
﹤0.01% 5418
2022
Q3
$22K Hold
15,364
﹤0.01% 5510
2022
Q2
$28K Buy
15,364
+15,039
+4,627% +$28.8K ﹤0.01% 5373
2022
Q1
$1K Buy
325
+311
+2,221% +$1.19K ﹤0.01% 7013
2021
Q4
$0 Sell
14
-1
-7% -$6 ﹤0.01% 7411
2021
Q3
$0 Sell
15
-31
-67% -$166 ﹤0.01% 7205
2021
Q2
$0 Buy
+46
New +$358 ﹤0.01% 7009

Other funds holding CTMX